会社概要
- 正式社名: ReaLi Tide Biological Technology Weihai Co., Ltd.
- 国際名称: 润辉生物技术(威海)有限公司 (ReaLi Tide Biological Technology (Weihai) Co., Ltd.), Weihai, Shandong, China
- ブランド名 / 商号: ReaLi Tide
- 登録国: China
- 住所: (Weihai) Co., Ltd., North Binhai Road & East Longhai Road,, Nanhai New District, Shandong • Shandong
- 従業員数: 250 - 499
説明:
ReaLi Tide Biological Technology (Weihai) Co., Ltd. is a cGMP-certified manufacturer of peptide and polysaccharide APIs. Its peptide APIs, Leuprorelin Acetate and Elcatonin, have been approved by China's NMPA, with the company being the only Elcatonin API producer in China, and it has also completed US DMFs for Leuprorelin Acetate, Argipressin, Octreotide Acetate, Oxytocin and Semaglutide; its polysaccharide APIs mainly include polysulfated glycosaminoglycan, pentosan polysulfate sodium, heparinoids, and Semaglutide and Tirzepatide intermediates and side chains, along with more than 100 types of PFA-free cosmetic peptides.
事業活動
原薬(API)
原薬メーカー
化粧品・パーソナルケア
サプライヤー
医薬用化学品
受託合成サービス提供者
ATC分類(解剖治療化学分類)
研究機関原薬メーカー
製造設備・プラントユーティリティ
原薬メーカー研究機関
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany
当社の製品・サービス
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
認証
GMP
ISO
証明
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す